Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Genetics and Cytogenetics

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0165-4608(96)00292-0PMID 9078292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International System for Human Cytogenetic Nomenclature

  2020cited by this paper
• Chronic Myelogenous Leukemia : A Concise Update

  2003cited by this paper
• Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.

  1997cited by this paper
• Very low level of major BCR-ABL expression in blood of some healthy individuals.

  1996cited by this paper
• Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.

  1996cited by this paper
• Chromosome abnormalities in the myeloproliferative disorders.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

  1995cited by this paper
• Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals.

  1995cited by this paper
• Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy

  1995cited by this paper
• Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia.

  1995cited by this paper
• Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.

  1995cited by this paper
• Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapy.

  1995cited by this paper
• Chromosome abnormalities in the myeloproliferative disorders.

  1995cited by this paper
• Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.

  1995cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia.

  1995cited by this paper
• Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia.

  1995cited by this paper
• Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.

  1994cited by this paper
• Philadelphia‐negative chronic myeloid leukaemia: detection by FISH of BCR‐ABL fusion gene localized either to chromosome 9 or chromosome 22

  1994cited by this paper
• Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid.

  1994cited by this paper
• Sequential cytogenetic study of patients after bone marrow transplantation.

  1994cited by this paper
• Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

  1994cited by this paper
• Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.

  1994cited by this paper
• Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

  1994cited by this paper
• Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.

  1994cited by this paper
• Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia Group.

  1994cited by this paper
• Chronic myelogenous leukemia: a concise update.

  1993cited by this paper
• Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization.

  1993cited by this paper
• Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.

  1993cited by this paper
• Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, BCR‐positive patients with chronic myeloid leukemia

  1993cited by this paper
• Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia.

  1993cited by this paper
• Impact of interferon alpha‐induced cytogenetic improvement on survival in chronic myelogenous leukaemia

  1993cited by this paper
• Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.

  1993cited by this paper
• Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

  1993cited by this paper
• Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase.

  1993cited by this paper
• The cytogenetic scenario of chronic myeloid leukemia.

  1993cited by this paper
• The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL.

  1993cited by this paper
• Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method.

  1993cited by this paper
• Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemia.

  1993cited by this paper
• Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group

  1993cited by this paper
• Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia

  1993cited by this paper
• Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase

  1993cited by this paper
• Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemia.

  1992cited by this paper
• Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.

  1991cited by this paper
• Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

  1990cited by this paper
• Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.

  1990cited by this paper
• Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects.

  1990cited by this paper
• Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia

  1988cited by this paper
• Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.

  1988cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation.

  1985cited by this paper
• Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myelogenous leukemia.

  1985cited by this paper
• Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

  1984cited by this paper
• Abnormalities of Chromosome 16

  1984cited by this paper
• Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?

  1984cited by this paper
• Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

  1983cited by this paper
• Therapeutic and prognostic value of initial chromosomal findings at the blastic phase of Ph1-positive chronic myeloid leukemia.

  1983cited by this paper
• Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases.

  1981cited by this paper
• Chromosomes in Ph1-positive chronic granulocytic leukemia. First International Workshop on Chromosomes in Leukaemia.

  1978cited by this paper

• Chronic Myeloid Leukemia in South Yemen

  2018cites this paper
• Calibration of interphase fluorescence in situ hybridization cutoff by mathematical models

  2016cites this paper
• Phytohemagglutinin-Induced Peripheral Blood Cytogenetics: A Valid Means for Diagnosis and Imatinib Therapy Monitoring of Chronic Phase Chronic Myeloid Leukemia Patients

  2015cites this paper
• [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].

  2014cites this paper
• Chronic Myeloid Leukaemias

  2013cites this paper
• Quantitative detection of BCR–ABL fusion gene and its application in monitoring chronic myeloid leukemia treatment

  2011cites this paper
• Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia

  2006cites this paper
• Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

  2005cites this paper
• Economic assessment on the management of chronic lymphocytic leukaemia

  2005cites this paper
• A significance of additional chromosomal aberrations and other variables on post transplantation outcome of patients with CML.

  2005cites this paper
• Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.

  2003cites this paper
• Interphase FISH studies of chronic myeloid leukemia.

  2002cites this paper
• Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.

  2002cites this paper
• Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.

  2002cites this paper
• Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia.

  2002cites this paper
• Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization.

  2000cites this paper
• Avaliação de doença residual mínima pós-transplante de medula óssea

  2000cites this paper
• Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.

  2000cites this paper
• Fluorescence in Situ Hybridization: Molecular Probes for Diagnosis of Pediatric Neoplastic Diseases

  2000cites this paper
• Comparative testing of peripheral blood and bone marrow for BCR-ABL transcripts in patients post allogeneic bone marrow transplantation and during interferon treatment for chronic myeloid leukemia.

  1999cites this paper
• Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells

  1999cites this paper
• Molecular pathology of leukemia and lymphoma.

  1999cites this paper
• A Special Fluorescent In Situ Hybridization Technique to Study Peripheral Blood and Assess the Effectiveness of Interferon Therapy in Chronic Myeloid Leukemia

  1998cites this paper
• Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.

  1998cites this paper
• A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.

  1998cites this paper
• High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia

  1998cites this paper